These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3968315)

  • 1. Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
    Ikeda N; Singh BN; Davis LD; Hauswirth O
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):303-10. PubMed ID: 3968315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.
    Himmel HM; Bussek A; Hoffmann M; Beckmann R; Lohmann H; Schmidt M; Wettwer E
    Br J Pharmacol; 2012 May; 166(1):276-96. PubMed ID: 22074238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic agonists inhibit the ATP-dependent potassium current and suppress the ventricle-Purkinje action potential dispersion.
    Magyar T; Árpádffy-Lovas T; Pászti B; Tóth N; Szlovák J; Gazdag P; Kohajda Z; Gyökeres A; Györe B; Gurabi Z; Jost N; Virág L; Papp JG; Nagy N; Koncz I
    Can J Physiol Pharmacol; 2021 Feb; 99(2):247-253. PubMed ID: 33242286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Flecainide on Multifocal Ectopic Purkinje-Related Premature Contractions in an R814W SCN5A Carrier.
    Ahamed H; Gopi A
    JACC Case Rep; 2024 Mar; 29(5):102223. PubMed ID: 38464806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-coupled Purkinje ectopy inducible by pharmacological and hyperventilation tests.
    Grifoni G; Haissaguerre M; Bongiorni MG; Benali K; Soldati E; Zucchelli G
    HeartRhythm Case Rep; 2024 Jan; 10(1):68-71. PubMed ID: 38264118
    [No Abstract]   [Full Text] [Related]  

  • 6. Flecainide-induced Increase in QRS Duration and Proarrhythmia during Exercise.
    Bordier P; Garrigue S; Bernard V; Haissaguerre M; Douard H; Broustet JP; Clementy J
    Clin Drug Investig; 1997 Jun; 13(6):326-37. PubMed ID: 27519494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide is effective against premature supraventricular and ventricular contractions during general anesthesia.
    Saishu T; Iwatsuki N; Tajima T; Hashimoto Y
    J Anesth; 1994 Sep; 8(3):284-7. PubMed ID: 23568113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.
    Martin CA; Grace AA; Huang CL
    Pflugers Arch; 2011 Oct; 462(4):495-504. PubMed ID: 21779762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.
    Aliot E; Capucci A; Crijns HJ; Goette A; Tamargo J
    Europace; 2011 Feb; 13(2):161-73. PubMed ID: 21138930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of class I antiarrhythmic drugs.
    Caron J; Libersa C
    Drug Saf; 1997 Jul; 17(1):8-36. PubMed ID: 9258628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of dridocainide on isolated canine, guinea-pig and human cardiac tissues.
    Pankucsi C; Hegedüs M; Kovács A; Szénási G; Szemerédi K; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):520-8. PubMed ID: 8751081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of flecainide acetate on stretched guinea pig left atrial muscle fibers.
    Inoue D; Shirayama T; Omori I; Inoue M; Sakai R; Ishibashi K; Miyazaki H; Yamahara Y; Tatsumi T; Asayama J
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):373-8. PubMed ID: 8364006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of disopyramide and flecainide on the kinetics of inward rectifier potassium channels in rabbit heart muscle.
    Martin DK; Nakaya Y; Wyse KR; Campbell TJ
    Br J Pharmacol; 1994 Mar; 111(3):873-9. PubMed ID: 8019764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug effects on the electrocardiogram. A review of their clinical importance.
    Symanski JD; Gettes LS
    Drugs; 1993 Aug; 46(2):219-48. PubMed ID: 7691513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical electrophysiologic effects of flecainide acetate.
    Mehta D; Camm AJ; Ward DE
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):599-603. PubMed ID: 3155304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel-blocking properties of flecainide, a class IC antiarrhythmic drug, in guinea-pig papillary muscles. An open channel blocker or an inactivated channel blocker.
    Kojima M; Hamamoto T; Ban T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):441-7. PubMed ID: 2544812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of flecainide enantiomers in canine Purkinje fibres.
    Smallwood JK; Robertson DW; Steinberg MI
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):625-9. PubMed ID: 2505091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast and slow blockade of sodium channels by flecainide in rabbit cardiac Purkinje fibres.
    Konzen G; Reichardt B; Hauswirth O
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):565-76. PubMed ID: 2168022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine Purkinje fibres.
    Varrò A; Knilans TK; Nànàsi PP; Rabloczky G; Lathrop DA
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):691-7. PubMed ID: 2096301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.
    Zehender M; Hohnloser S; Just H
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):515-30. PubMed ID: 1854661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.